Understanding how inhaled Mycobacterium tuberculosis achieves dramatic replication and crosses the alveolar barrier to establish systemic latent infection, before adaptive immunity is elicited in humans, is limited by the small infecting inoculum carried in aerosol droplets (1-5 mm diameter) and the inability to identify the time of infection. M. tuberculosis is believed to disseminate via infected macrophages. However, like other invasive bacterial pathogens, M. tuberculosis could also cross the barrier directly using adhesins and toxins. An in vitro alveolar barrier mimicking the gas-exchange regions of the alveolus was devised comprising monolayers of human alveolar epithelial and endothelial cells cultured on opposing sides of a basement membrane. Migration of dissemination-competent strains of M. tuberculosis, and dissemination-attenuated M. tuberculosis and Mycobacterium bovis mutant strains lacking adhesin/toxin ESAT-6 and adhesin HBHA were tested for macrophage-free migration across the barrier. Strains that disseminate similarly in vivo migrated similarly across the in vitro alveolar barrier. Strains lacking ESAT-6 expression/secretion were attenuated, and absence of both ESAT-6 and HBHA increased attenuation of bacterial migration across the barrier. Thus, as reported for other bacteria, M. tuberculosis utilizes adhesins and toxins for macrophageindependent crossing of the alveolar barrier. This in vitro model will allow identification and characterization of molecules/mechanisms employed by M. tuberculosis to establish systemic latent tuberculosis infection during primary infection.
INTRODUCTION
Tuberculosis (TB) is initiated by a few Mycobacterium tuberculosis bacilli entering the alveoli. In TB-endemic countries, infection mostly occurs during childhood, and while *10 % of the infected individuals progress to primary TB, the remaining infections lead to latent TB infection (LTBI) . Approximately 15-20 % of the reactivation TB in immunocompetent individuals, and *50 % in human immunodeficiency virus (HIV)-positive cases, occurs exclusively at extrapulmonary sites, indicating systemic bacterial dissemination during primary infection.
Studies in animal models demonstrate extensive bacterial replication (w20 000-fold) in the lungs, and systemic dissemination during the first few days and weeks (2-3 weeks), post-aerosol infection and prior to the elicitation of adaptive immunity (Wolf et al., 2008; Chackerian et al., 2002; Ordway et al., 2007) . Earlier studies reported the presence of M. tuberculosis DNA in normal lung and adipose tissue from autopsied non-tuberculous subjects living in TB-endemic settings (Hernández-Pando et al., 2000; Neyrolles et al., 2006) . Subsequently, LTBI with viable M. tuberculosis in macrophages, endothelial cells (ECs) and/or epithelial cells in autopsied tissue from lungs, liver, spleen and kidney was demonstrated (Barrios-Payán et al., 2012) . In many subjects, LTBI was detected only in the extrapulmonary sites. The same cell types infected with M. tuberculosis are also present in apparently normal tissues in the mouse model of latency (Barrios-Payán et al., 2012) . Together, these studies confirm the establishment of systemic LTBI during primary infection (Barrios-Payán et al., 2012; Laal, 2012) .
Systemic dissemination is fundamental to the pathogenesis of M. tuberculosis (Vidal Pessolani et al., 2003) ; however, the understanding M. tuberculosis dissemination during primary infection in humans is limited by the small number of the bacteria that are inhaled, and the inability to identify the time of infection. It is believed that dissemination of M. tuberculosis occurs by the 'Trojan horse' mechanism, wherein alveolar macrophages that phagocytose M. tuberculosis invade the epithelium, elicit inflammatory responses and recruit macrophages from the blood stream, which in turn transport the bacteria systemically. However, other bacteria also utilize repertoires of adhesins, which promote adherence/invasion of the barrier cells, and toxins, which lyse these cells to increase barrier permeability, in order to directly cross their relevant barriers. Studies with an in vitro alveolar bilayer model (apical A549 : basolateral EAhy926) implicated the use of both the Trojan horse and the 'direct migration' mechanisms by M. tuberculosis (Bermudez et al., 2002) . However, EAhy926 is a hybrid of human umbilical vein ECs and alveolar epithelial cells (AECs) (A549 cells), and not a purely EC line. Additionally, this model lacked a basement membrane (BM) between the AEC and EC bilayer, and the direct bacterial migration of M. tuberculosis could be ascribed to an incomplete BM.
M. tuberculosis expresses several adhesins, heparin-binding haemagglutinin (HBHA; Rv0475), malate synthase (MS; Rv1837c) and ESAT-6, that enable bacterial attachment to the AECs (Pethe et al., 2001; Kinhikar et al., 2006 Kinhikar et al., , 2010 . HBHA, a heparin sulphate proteoglycan receptorbinding adhesin, promotes bacterial adherence to AECs, but not to macrophages, and participates in extrapulmonary dissemination in intranasally infected mice, but not in intravenously infected mice (Pethe et al., 2001) . ESAT-6 is both a laminin-binding adhesin that binds AECs and a pore-forming toxin that lyses macrophages and AECs in vivo and in vitro (Hsu et al., 2003; Kinhikar et al., 2010; McDonough & Kress, 1995) . The absence of the esat-6 and ESX-1 locus (encoding the system required for ESAT-6 secretion) is a major contributing factor for the attenuation of Mycobacterium bovis bacillus Calmette-Guérin (BCG) (Hsu et al., 2003) . The secretion of ESAT-6 is reported to be indirectly regulated by the virulenceassociated two-component system response regulator PhoP, such that a functional PhoP is required for ESAT-6 secretion (Frigui et al., 2008; Ryndak et al., 2008) . A natural single nucleotide mutation in the DNA-binding region of PhoP in the attenuated M. tuberculosis H37Ra prevents ESAT-6 secretion, and introduction of wild-type H37Rv phoP restores ESAT-6 secretion and also increases H37Ra virulence potential (Frigui et al., 2008) . Interestingly, an M. tuberculosis phoP mutant is severely attenuated in animal models (Ryndak et al., 2008) . The role of PhoP in M. tuberculosis dissemination from the lung has not been explored.
Transcripts for ESAT-6, MS and HBHA are upregulated in M. tuberculosis in AECs (Ryndak et al., 2015; Delogu et al., 2006) , while they are unaffected in bacteria replicating in macrophages (Schnappinger et al., 2003; Fontán et al., 2008) . M. bovis BCG, M. tuberculosis H37Rv Desat-6 and M. bovis BCG Dhbha are attenuated for dissemination from the lungs in animal models (Lewis et al., 2003; Pethe et al., 2001) . Together, these results raise the possibility that, like other invasive bacteria, M. tuberculosis also uses adhesins and toxins to achieve direct migration across the alveolar barrier by transcellular and/or paracellular mechanisms.
To investigate roles for HBHA and ESAT-6 in the direct migration of M. tuberculosis across the alveolar barrier, we modified the in vitro alveolar barrier to address the shortcomings of the earlier model (Bermudez et al., 2002) . While AECs express the components of the BM in vitro, the provision of exogenous laminin is necessary for complete BM formation (Furuyama & Mochitate, 2000) . Our model, therefore, incorporates a BM between the AEC and EC monolayers, and includes the more relevant human pulmonary artery EC line HPAE-26.
Studies with our human in vitro alveolar barrier demonstrate the macrophage-free migration of clinical M. tuberculosis strains. ESAT-6 mutants, M. bovis BCG and M. tuberculosis H37Rv Desat-6, and ESAT-6 secretiondeficient M. tuberculosis H37Rv DphoP, are similarly attenuated for transmigration; and the M. bovis BCG Dhbha (lacking both ESAT-6 and HBHA) demonstrates greater attenuation of transmigration compared to strains lacking ESAT-6 alone. These results provide evidence that, like other bacteria that invade by crossing the relevant mucosal barrier, M. tuberculosis may also employ the synergistic activity of adhesins and toxins to achieve macrophage-independent direct transmigration across the alveolar barrier during primary infection.
METHODS
M. tuberculosis infection and replication in HPAE-26 cells. The earlier in vitro alveolar bilayer barrier included bilayers of AECs (A549; human type II AECs), but a non-physiological EC line (EAhy926), which is a hybrid of human umbilical vein ECs and A549 cells) (Bermudez et al., 2002) . To confirm that human pulmonary artery ECs (HPAE-26) (Coriell WC00107) get infected with and support M. tuberculosis replication ( Fig. 1 ), 5|10 5 HPAE-26 per well were seeded into the wells of a 24-well plate (or glass coverslips in wells for microscopy) pre-coated with 0.1 % pig gelatin for 10 min and cultured in F12K medium supplemented with 10 % fetal bovine serum (FBS), 0.1 mg heparin ml 21 and 0.03 mg endothelial cell growth factor ml 21 , and grown to confluency. Confluent monolayers were washed with F12K medium and infected with M. tuberculosis H37Rv at m.o.i. values of 1 : 1 and 5 : 1 bacteria to cells for 2 h. Infected cells were washed three times with F12K medium and the remaining extracellular bacteria were killed by amikacin treatment (200 mg ml 21 ) for 1 h. Amikacin was removed by washing three times with F12K medium and replaced with F12K, 1 % FCS. At the indicated time points, and in triplicate, infected cells were washed three times with F12K medium and lysed with 0.1 % Triton X-100 for c.f.u. measurement ( Fig. 1a ) or fixed with 60 % acetone for 20 min for staining and light microscopy ( Fig. 1b ). Lysates were serially diluted, plated onto Middlebrook 7H11 plates and incubated at 37 uC for assessing c.f.u. Fixed infected cells on coverslips were acid-fast stained by Kinyoun stain (TB stain kit K; Fisher Scientific), visualized under oil-emersion (Nikon Eclipse 80i light microscope) and images captured using a mounted Nikon CoolPix 9400 digital camera.
Human in vitro alveolar barrier. To mimic the human in vivo alveolar barrier ( Fig. 2a, b ), BM preparation (Matrigel; BD Biosiences), diluted in ice-cold serum-free medium, was pipetted (60 mg cm 22 ) onto 3 mm porous membranes of transwell permeable supports (Costar) and incubated for 1 h at 37 uC followed by overnight at room temperature. The polymerized BM was moistened for 1-2 h at 37 uC with serum-free F12K medium, surplus medium was removed and the inserts placed upside-down in the wells of a 24-well plate. The exposed bottom sides of the transwells were seeded with 10 5 HPAE-26 cells in 100 ml F12K containing glutamine, 10 % FBS, 0.05 mg heparin ml 21 and 0.02 mg EC growth supplement ml 21 (ECGS), and the cellseeded inverted transwells left undisturbed for *45 min to allow cellular adherence. The HPAE-26-seeded inserts were gently turned into an upright position into wells containing 500 ml F12K-glutamine/ FBS/heparin/ECGS, and 200 ml F12K-glutamine/10 % FBS was added to the upper chambers. The slower growth rate of HPAE-26 cells compared to A549 cells requires that HPAE-26 cells be seeded to the basal surface of the BM-coated transwells 2 days prior to the seeding of A549 cells to the apical surface, to enable confluent monolayers of both cell lines to form simultaneously. At 48 h post-HPAE-26 seeding, the upper chambers were seeded with 10 5 A549 cells (200 ml) (ATCC CCL-185). Transwells with similarly seeded HPAE-26 or A549 cells alone were included as controls. Starting 1 day post-seeding for each cell type, the transmembrane electrical resistance (TER) of the monolayers/bilayer in triplicate wells was monitored daily using a MilliCell ERS Volt/Ohm meter (Millipore) until stabilization (Fig. 2c ). The TERs of duplicate BM-infused, cell-free transwells were also recorded daily to account for fluctuations in TER readings. The alveolar lumen is lined with a monolayer of type I (light grey) and type II (blue) AECs, which are separated from the alveolar capillary ECs (dark grey) by interstitial ECM or by a fused BM. To cross this barrier directly, M. tuberculosis (pink) must invade and replicate in the AECs, exit these cells, cross the ECM/BM/ECs and exit to the blood circulation. (b) The in vitro alveolar barrier was constructed by growing monolayers of A549 (human type II AEC line) and HPAE-26 (human pulmonary artery EC line) cells on opposite sides of a BM-infused transwell permeable membrane. The upper chamber (A549 side) represents the alveolar lumen, while the lower chamber (HPAE-26 side) represents entrance into the blood circulation. (c) Daily TER measurements (V cm 22 ) monitored in parallel and in triplicate; BM-infused transwells seeded with HPAE-26 alone (red diamonds), A549 alone (green squares), or both HPAE-26 and A549 (blue/white triangles) starting 1 day post-seeding. TER measurements for BM-infused transwells with no cells (purple circles) were also taken in duplicate and in parallel to control for fluctuations in meter readings. Measurements were taken up until 9 days post-HPAE-26 seeding and 7 days post-A549 seeding.
Mycobacterial strains. M. tuberculosis H37Rv and clinical isolates CDC1551 and HN878 exhibit similar dissemination from the lungs in aerosol-infected animal models (Palanisamy et al., 2008) . M. tuberculosis Desat-6 and M. bovis BCG (attenuated for expression of ESAT-6 and in vivo dissemination) (Hsu et al., 2003; Lewis et al., 2003; Guinn et al., 2004) , and M. tuberculosis H37Rv DphoP (deficient for secretion of ESAT-6) (Frigui et al., 2008) , were tested in parallel with wild-type M. tuberculosis H37Rv. In addition, M. bovis BCG Dhbha (attenuated for expression of both ESAT-6 and HBHA) (Pethe et al., 2001) was evaluated for migration across the human in vitro alveolar barrier.
Trans-alveolar barrier migration experiments. Mid-exponential phase bacteria [cultured in 7H9 broth supplemented with 0.2 % (v/v) glycerol, 10 % Albumin/Dextrose/Catalase supplement (ADC) and 0.05 % Tween 80] in single-cell suspensions (target *10 6 -10 7 c.f.u.; 200 ml) were added to the upper chambers of fully formed in vitro alveolar barriers in triplicate for each strain. To prepare the single-cell suspensions, 50 ml bacterial culture was centrifuged at 3000 r.p.m. for 20 min and the bacterial pellet resuspended in 20 ml PBS, 0.05 % Tween 80. This suspension was centrifuged again at 3000 r.p.m. for 20 min and the bacterial pellet resuspended in 5 ml PBS, 0.05 % Tween 80 in a 50 ml conical Falcon tube. Sterile 3 mm glass beads were added to just fill the cone of the tube. Bacteria and beads were then subjected to vigorous vortexing for 5 min to aid in dispersing clumps. The tube was set upright undisturbed to allow any clumps to settle. The top 3.5 ml was carefully removed and transferred to a 15 ml conical Falcon tube and again allowed to sit undisturbed for 30 min, after which the top 2.5 ml was carefully removed and transferred to a new tube. The suspension in this tube was again allowed to settle for a final 15 min and the top 2.4 ml removed to be used in the preparation of the inocula. One half millilitre of the bacterial preparation was diluted with 0.5 ml PBS, 0.05 % Tween 80 and the optical density (wavelength 600 nm) measured to estimate the number of bacteria in the final suspension. Suspensions for each bacterial strain were diluted accordingly to obtain target concentrations as close as possible across all strains being tested. Inoculum c.f.u. numbers were verified by plating serial dilutions on 7H11 Middlebrook agar (Table S1, Table S1 ). The Mann-Whitney one-tailed test was used to determine statistical significance (GraphPad Prism 5 software); P values j0.05 were considered statistically significant. 
RESULTS

HPAE-26 cells are infected with and support M. tuberculosis replication
Human cell line A549 is widely used for studies of interactions of other pulmonary pathogens, e.g. Influenza A, Streptococcus pneumoniae, Staphylococcus aureus, etc., with human AECs. In contrast to the extensive information on M. tuberculosis invasion and replication in A549 cells, studies with M. tuberculosis infection of human HPAE-26 ECs have not been reported. Our results demonstrate that at an m.o.i. of 1 : 1 and 5 : 1 intra-HPAE-26 M. tuberculosis H37Rv c.f.u. numbers increased by *1.7and *3.6-fold by day 3, and *12.8and *8.5-fold by day 5, respectively (Fig. 1a) . Earlier studies have shown that M. tuberculosis initiates necrosis of A549 cells at day 3 post-infection at an m.o.i. of 10 : 1 (Dobos et al., 2000) . The reduction in recovery of intracellular M. tuberculosis at day 5 post-infection at the higher m.o.i. (5 : 1) and not at the lower m.o.i. (1 : 1) indicates that M. tuberculosis replication in HPAE-26 cells also initiates lysis by day 5. Therefore, for the subsequent migration experiments, the time point of 72 h was used to obtain quantifiable bacterial migration prior to the destruction of the cellular integrity of either cell type of the bilayer. Kinyoun staining of fixed M. tuberculosis-infected HPAE-26 revealed increasing numbers of acid-fast bacteria in the cells over time, confirming the intracellular bacterial replication in these cells (Fig. 1b) . Thus M. tuberculosis infects ECs and replicates intracellularly in these cells.
Human in vitro alveolar barrier
A bilayer model of the alveolar barrier based on monolayers of human AECs and ECs on opposing sides of a BM-infused permeable transwell membrane was devised (Fig. 2b) . There was no effect on morphology or cellular replication of either cell type during growth on BM (data not shown). The developing monolayers of the two cell types were monitored individually and in parallel with the bilayer by measuring the TER between the upper and bottom chambers of triplicate wells (Fig. 2c ). TER measurements for EC-seeded transwell inserts increased from 1 day post-seeding (*382 + 14 V cm 22 ) to peak/ plateau at 8 days post-seeding (*464 + 64 V cm 22 ). TER values in AEC-seeded transwell inserts also increased from 1 day post-seeding (*398 + 4 V cm 22 ) to peak/ plateau 6 days post-seeding (*472 + 19 V cm 22 ). The initial TER for the bilayer (419 + 11 V cm 22 ) at 1 day post-A549 seeding increased to peak/plateau at *493+9 V cm 22 on day 8 post-EC-seeding (day 6 post-AEC-seeding) and is higher than the TER for either monolayer alone. The resulting bilayer mimics the gas-exchange regions of the human alveolar barrier in that the AECs and ECs share a BM with the apical AEC-seeded side representing the alveolar lumen and the basolateral EC-seeded side representing the capillary lumen ( Fig. 2a, b) .
Migration of M. tuberculosis H37Rv and clinical isolates across the human in vitro alveolar barrier M. tuberculosis H37Rv, CDC1551 and HN878, strains that disseminate similarly in vivo (Palanisamy et al., 2008) , demonstrated similar migration across the human in vitro alveolar barrier (Fig. 3a) . At 72 h post-infection, there was no statistically significant difference between the per cent migration of the three strains (0.99 + 0.33 %; 1.0 + 0.14 %; 1.0 + 0.13 %, respectively) suggesting that the bacterial factors and mechanisms responsible for direct migration across the alveolar barrier are conserved and similar in all three strains.
Migration of in vivo dissemination-attenuated mycobacterial strains across the human in vitro alveolar barrier
The migrations of M. tuberculosis H37Rv Desat-6, M. bovis BCG and M. tuberculosis H37Rv DphoP were evaluated in parallel with M. tuberculosis H37Rv at 72 h post-infection (Fig. 3b) . The three mutant strains were all similarly attenuated for migration across the human in vitro alveolar barrier (*50 % compared to H37Rv). There was no significant difference between the per cent migrations of the three mutant strains (Fig. 3b) . These results demonstrate a role for ESAT-6 in the direct crossing of M. tuberculosis across the alveolar barrier.
Disruption/deletion of hbha in M. tuberculosis or M. bovis BCG causes attenuated dissemination from the lungs of intranasally infected mice (Pethe et al., 2001) . The migrations of H37Rv, BCG and BCG Dhbha were also evaluated in parallel (Fig. 3b ). Migration of BCG Dhbha was 40 % lower than BCG (P value50.05) and 72 % lower than H37Rv (P value50.05). Migration of BCG Dhbha was diminished compared to both M. tuberculosis Desat-6 and M. tuberculosis DphoP as well as BCG, all of which express hbha in a background attenuated for esat-6 expression and/or ESAT-6 secretion. Importantly, simultaneous deficiency of two adhesins demonstrated increased attenuation of bacterial migration across the barrier.
Thus, strains that exhibit attenuated dissemination from the lung in vivo in animal models are also attenuated for migration across the human in vitro alveolar barrier, validating the model for studies of macrophage-independent M. tuberculosis dissemination across the alveolar barrier.
DISCUSSION
In vitro models of mucosal barriers have enhanced our understanding of the mechanisms used by pathogens such as Shigella spp., enteropathogenic Yersinia and Streptococcus pneumoniae, just to name a few, to cross their relevant barriers (McCormick, 2003) . To investigate the M. tuberculosis proteins and the mechanisms employed by M. tuberculosis to directly cross the alveolar barrier during primary infection, we devised an accurate mimic of the human in vivo alveolar barrier. M. tuberculosis strains that disseminate similarly in animal models migrated similarly across this human in vitro alveolar barrier (Fig. 3a) . Importantly, BCG and M. tuberculosis Desat-6, which are attenuated for dissemination from the lungs in aerosolinfected mice, are equally attenuated for transmigration across the human in vitro alveolar barrier (Fig. 3b) , as is M. tuberculosis DphoP (deficient for ESAT-6 secretion) (Fig. 3b) . The BCG Dhbha strain demonstrated enhanced attenuation for macrophage-independent transmigration compared to the mutants lacking only ESAT-6 ( Fig. 3b ). Together, these results provide evidence for synergistic participation of ESAT-6 and HBHA in direct migration across the alveolar barrier in humans.
The massive replication of M. tuberculosis in a nonmigrating, non-antigen-presenting compartment of the lungs in aerosol-infected mice (Wolf et al., 2008) , the presence of M. tuberculosis in the AECs in non-TB humans (Barrios-Payán et al., 2012; Hernández-Pando et al., 2000) , and the enhanced infectivity of M. tuberculosis retrieved from type II AECs to cross a bilayer of A549 and Eahy926 cells (Bermudez et al., 2002) indicate that M. tuberculosis exploits the non-phagocytic intra-AEC environment both to replicate actively (Wolf et al., 2008; Mehta et al., 1996) and to transition to a disseminative phenotype. This is supported by the transcriptional profile of M. tuberculosis replicating in human type II AECs (Ryndak et al., 2015) . Thus, intra-AEC M. tuberculosis downregulate DosR (DevR) regulon genes and dormancyinducing stress-related genes, and upregulate genes involved in energy production, protein synthesis and cellwall synthesis (Ryndak et al., 2015) . In contrast, intramacrophage M. tuberculosis show upregulation of DosR (DevR) regulon genes and stress-related genes associated with transition to dormancy (Schnappinger et al., 2003; Fontán et al., 2008) . While esat-6 is downregulated in M. tuberculosis in macrophages, esat-6 and five genes encoding ESAT-6-like proteins, esxH, esxW, esxJ, esxK and esxP, are upregulated in M. tuberculosis in type II AECs (Ryndak et al., 2015) , as are genes encoding the laminin-binding adhesin MS, which promotes bacterial adherence to type II AECs (Kinhikar et al., 2006) , Ag 85C (Rv0129c), which is a member of the fibronectinbinding Ag85 complex (Kuo et al., 2012) , and Rv3922c, which has sequence similarity to haemolysins of other bacteria. Importantly, transcripts for these genes are unaffected during bacterial residence in macrophages (Schnappinger et al., 2003; Fontán et al., 2008) .
Bacterial dissemination requires that after crossing the alveolar barrier, M. tuberculosis survive and adapt to the blood to eventually infect the cells of other organs. Our studies of ex vivo adaptation of M. tuberculosis to whole blood from HIV2 and HIV+ subjects demonstrated that esat-6 is upregulated in M. tuberculosis replicating in both environments (Ryndak et al., 2014) ; esat-6 was the most upregulated of *150 upregulated M. tuberculosis genes in blood from HIV+ patients. As in AECs, upregulation of esat-6 was accompanied by upregulation of esxW, esxJ, esxK and esxP. The higher susceptibility of HIV+ patients to M. tuberculosis infection as well as disseminated and extrapulmonary TB further emphasizes a potential role for these ESAT-6-like proteins in the dissemination of M. tuberculosis.
Other bacterial pathogens cross the relevant mucosal barriers by synergistic use of repertoires of adhesins and lysins/toxins (Doran et al., 2013) . Adhesins enable bacterial anchoring to the cells of the barrier via binding to components of the extracellular matrix (ECM)/BM (laminin, proteoglycans, collagen, fibronectin, elastin, etc.) , and toxins facilitate dissemination by increasing barrier permeability via cell lysis. The upregulation of transcripts for east-6 and hbha in M. tuberculosis replicating in AECs (Ryndak et al., 2015; Kinhikar et al., 2010; Delogu et al., 2006) , and the greater attenuation of BCG Dhbha strain for migration across the in vitro alveolar barrier, is reminiscent of the synergism of adhesin(s) and toxin(s) reported for other bacteria for direct dissemination. Thus, Listeria monocytogenes adhesins (FbpA, ActA, InlA) promote attachment/invasion of small intestinal enterocytes (Dramsi et al., 2004; Suárez et al., 2001; Bierne et al., 2007) and listeriolysin O (LLO), a pore-forming toxin, impairs the integrity of the intestinal epithelial barrier (Richter et al., 2009) . Streptococcus pneumoniae adhesins PspC, CbpA and PsaA promote adherence to type II AECs (Nobbs et al., 2009; Chen et al., 2010) ; while pneumolysin (Ply) is cytotoxic to AECs and ECs resulting in increased alveolar permeability (Marriott et al., 2008) . Staphylococcus aureus adhesin SpA promotes invasion across airway epithelial cells via paracellular junctions, alters the epithelial barrier to expose ECM and enables the Staphylococcus aureus fibronectin-binding proteins (FnbP) to bind to ECs (Soong et al., 2011; Sinha et al., 1999) , and Staphylococcus aureus a-toxin detaches epithelial cells from the BM to increase the microvascular EC barrier permeability to promote invasive disease (Phillips et al., 2006; Powers et al., 2012) .
That relatively low numbers of bacteria (j1 %) cross the in vitro alveolar barrier is likely a consequence of the limited time for which the in vitro barrier can be maintained (3-4 days). The extensive replication of M. tuberculosis in AECs leads to necrosis and lysis (Dobos et al., 2000; McDonough & Kress, 1995) , and subsequent infection of the adjacent AECs (Castro-Garza et al., 2002) . Thus, in vivo, M. tuberculosis would replicate in the infected AECs, transform to a disseminative phenotype, lyse the cells, spread to adjacent cells and continue to replicate/ lyse, simultaneously disseminating systemically to achieve widespread infection before adaptive immune responses that induce latency are elicited (Wolf et al., 2008) .
The lack of ESAT-6 and HBHA does not completely abolish dissemination from the mouse lungs (Pethe et al., 2001; Lewis et al., 2003) or migration across the human in vitro alveolar barrier (Fig. 3b ), indicating participation of additional bacterial factors. While the functional activities of EsxH, EsxW, EsxJ, EsxK and EsxP are not known, like ESAT-6, these ESAT-6-like proteins are small (*100 aa) secreted proteins that lack a secretion signal and share a known or predicted helix-turn-helix structure and central WXG motif (Pallen, 2002) . The conservation of these structural features with ESAT-6, despite a lack of significant sequence similarity, suggests similarity in function; thus, indicating a potential role for these proteins as adhesins and/or toxins. The human in vitro alveolar barrier described herein will enable exploration of their role in bacterial dissemination from the lungs.
Strain/lineage-specific differences in virulence phenotype and tropism for extrapulmonary sites are increasingly reported for M. tuberculosis (Gagneux & Small, 2007; Palanisamy et al., 2009; Click et al., 2012; Caws et al., 2008) . Thus, M. tuberculosis strains from the Cerebral Spinal Fluid (CSF) of TB meningitis patients disseminate more efficiently than strains from pulmonary TB patients (Hernández-Pando et al., 2010) . W-Beijing strains of the East Asian lineage are three times more likely to cause extrapulmonary TB compared to non-Beijing strains (Kong et al., 2007) . The highly transmissible Beijing and F15/LAM4/ KZN M. tuberculosis families adhere and invade type II AECs with greater efficiency than genetically different clinical strains and M. tuberculosis H37Rv (Ashiru et al., 2010) . The human in vitro alveolar barrier could also enable an understanding of how M. tuberculosis strains/lineages differ in their dissemination ability.
There are limitations to our human in vitro alveolar barrier model. First, the in vivo alveolar barrier comprises both type I and type II AECs; the model includes only the latter cell type. There is no true type I AEC line available, and the current type I model cell line, WI-26, which is lysed by ESAT-6 (Kinhikar et al., 2010) and CFP21 (Vir et al., 2014) , is a lung fibroblast line with epithelial-like morphology. Second, our model mimics only the gas-exchange region of the alveoli where there is no interstitial ECM. Other adhesins and toxins may interact with different ECM components in the interstitium. While the contribution of inflammatory responses that damage the alveolar barrier in vivo were not evaluated in this study, our bilayer model provides the opportunity to dissect the contribution of inflammatory cytokines and chemokines on M. tuberculosis dissemination during primary infection. Furthermore, the current model will contribute to the identification and characterization of additional M. tuberculosis adhesins and lysins that participate in direct bacterial dissemination from the lungs, allow exploration of the pathogenalveolar interactions of M. tuberculosis strains with tropism for extrapulmonary sites of infection, and promote understanding of the mechanisms employed by M. tuberculosis to establish systemic latent infection.
